Clinical Trial Update: Efficacy and Safety Study of Benralizumab in Patient With Eosinophilic Chronic Rhinosinusitis With Nasal Polyps (ORCHID) [Phase 3]

View source ↗

Summary

A Phase 3 trial (ORCHID) evaluating benralizumab for eosinophilic chronic rhinosinusitis with nasal polyps was terminated, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Eosinophilic Chronic Rhinosinusitis
• Nasal Polyposis

Drugs mentioned

• Benralizumab (benralizumab)

Snippet

Sponsor: AstraZeneca | Conditions: Nasal Polyposis, Eosinophilic Chronic Rhinosinusitis | Phase 3 | Status: TERMINATED | Results posted: 2026-02-19